[Successful thrombolysis after an ischemic stroke in an 92-year-old woman]

Dtsch Med Wochenschr. 2008 Dec;133(49):2559-61. doi: 10.1055/s-0028-1105852. Epub 2008 Nov 27.
[Article in German]

Abstract

History: A 92-year-old woman was found by her domestic help to have suddenly sustained a left-sided weakness in her limbs 30 minutes after she had seemed perfectly well. She had undergone a total hip replacement 4 weeks previously.

Admission findings: Her National Institutes of Health stroke scale (NIHSS) score was 18. She had a left hemiparesis with sensory deficits, left-sided neglect, dysarthria and aphasia.

Investigations: Stroke magnetic resonance imaging (MRI) confirmed the suspected diagnosis of ischemic infarction within the territory supplied by the right middle cerebral artery, with diffusion in the periventricular region and the cortex of the right basal temporal lobe.

Treatment and further course: Recombinant tissue plasminogen activator (rtPA) was administered intravenously. At completion of the infusion the neurological deficits had lessened. The NIHSS was reduced to 6 and ultimately was 0.

Conclusion: Patients older than 80 years who have sustained a stroke can benefit from rtPA administration. Stroke-MRI is a valuable tool in the early diagnosis and may improve the safety of thrombolysis, especially in borderline situations such as advanced age or in the face of a closing "time window". Currently the mismatch concept (greater perfusion deficit than diffusion abnormality) does not replace the time criterion.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged, 80 and over
  • Aphasia / etiology
  • Brain Ischemia / complications
  • Brain Ischemia / diagnosis
  • Brain Ischemia / drug therapy*
  • Dysarthria / etiology
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / diagnosis
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Paresis / etiology
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / therapeutic use*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator